Get the Stockscreener App
1.33
3.91%
0.05
Pre-market:
1.33
Telomir Pharmaceuticals Inc Stock (TELO) Forecast
The Telomir Pharmaceuticals Inc (TELO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.7269, representing a +480.97% increase from the current price of $1.33. The highest analyst price target is $7.5095, and the lowest is $7.9443.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TELO Price Target
Average 10.97
(+724.62% Upside)
Is Telomir Pharmaceuticals Inc (TELO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.68 | Neutral |
| STOCH(9,6) | 42.14 | Neutral |
| STOCHRSI(14) | 35.22 | Neutral |
| MACD(12,26) | 0.0166 | Sell |
| ADX(14) | 15.64 | Neutral |
| William %R | -48.02 | Neutral |
| CCI(14) | -4.217 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.321
Buy
|
1.3104
Buy
|
| MA20 |
1.3138
Buy
|
1.2987
Buy
|
| MA50 |
1.2599
Buy
|
1.2924
Buy
|
| MA100 |
1.3233
Buy
|
1.3616
Sell
|
| MA200 |
1.4439
Sell
|
1.7845
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, TELO could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on TELO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.68 indicates that TELO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 42.14 indicates that TELO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.22 indicates that TELO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 15.64 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.217 indicates that TELO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TELO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Telomir Pharmaceuticals Inc financial reports and earnings history, Telomir Pharmaceuticals Inc (TELO) stock could reach $37.17 by 2030, $109.70 by 2040 and $168.47 by 2050. See the projected annual prices until 2050 of the Telomir Pharmaceuticals Inc stock below:
- Telomir Pharmaceuticals Inc (TELO) is expected to reach an average price of $80.97 in 2035, with a high prediction of $69.27 and a low estimate of $61.71. This indicates an $5,988% rise from the last recorded price of $1.33.
- Telomir Pharmaceuticals Inc (TELO) stock is projected to chart a bullish course in 2040, with an average price target of $104.40, representing an $7,749% surge from its current level. The forecast ranges from a conservative $106.45 to a sky-high $109.70.
- Our analysts predict Telomir Pharmaceuticals Inc (TELO) to jump 11,421% by 2045, soaring from $153.58 to an average price of $153.23, potentially reaching $157.03. While $153.58 is the low estimate, the potential upside is significant.
- Telomir Pharmaceuticals Inc (TELO) stock is expected to climb by 2050, reaching an average of $160.15, a $11,941% jump from its current level. However, a wide range of estimates exists, with high and low targets of $168.47 and $160.60, respectively, highlighting the market's uncertainty.
Telomir Pharmaceuticals Inc Stock (TELO) Year by Year Forecast
Telomir Pharmaceuticals Inc Stock (TELO) Price Forecast for 2026
The predicted value for Telomir Pharmaceuticals Inc (TELO) in 2026 is set at an average of $9.0968. Estimates vary from a peak of $13.16 to a trough of $5.0343, indicating an +583.97% surge from the present price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $10.30 | $7.9443 | $7.5095 | +674.73% |
| May, 2026 | $5.8129 | $8.5529 | $9.3034 | +337.06% |
| June, 2026 | $6.8074 | $6.8477 | $6.767 | +411.83% |
| July, 2026 | $9.9215 | $10.02 | $9.6282 | +645.98% |
| August, 2026 | $9.9079 | $11.96 | $11.23 | +644.96% |
| September, 2026 | $8.5636 | $8.6612 | $8.466 | +543.88% |
| October, 2026 | $11.76 | $12.11 | $11.75 | +783.86% |
| November, 2026 | $14.13 | $12.31 | $13.16 | +962.35% |
| December, 2026 | $10.75 | $10.47 | $10.91 | +708.39% |
Telomir Pharmaceuticals Inc Stock (TELO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Telomir Pharmaceuticals Inc (TELO) is $15.81, with a high forecast of $20.87 and a low forecast of $10.74. This indicates an +1,088% increase from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $14.24 | $10.74 | $13.87 | +970.35% |
| February, 2027 | $15.14 | $14.19 | $14.48 | +1,038% |
| March, 2027 | $12.66 | $12.29 | $15.09 | +852.14% |
| April, 2027 | $16.74 | $12.44 | $14.68 | +1,159% |
| May, 2027 | $18.32 | $16.27 | $15.98 | +1,278% |
| June, 2027 | $13.78 | $14.10 | $17.02 | +935.83% |
| July, 2027 | $19.51 | $14.14 | $13.56 | +1,367% |
| August, 2027 | $18.09 | $18.35 | $18.10 | +1,260% |
| September, 2027 | $15.07 | $17.81 | $18.94 | +1,033% |
| October, 2027 | $15.55 | $15.84 | $15.26 | +1,069% |
| November, 2027 | $20.08 | $20.43 | $20.22 | +1,410% |
| December, 2027 | $19.36 | $20.48 | $20.87 | +1,355% |
Telomir Pharmaceuticals Inc Stock (TELO) Price Forecast for 2028
In 2028, Telomir Pharmaceuticals Inc (TELO) is projected to reach an average price of $23.12, with a high projection of $28.70 and a low estimate of $17.54. This indicates an +1,638% rise from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $17.70 | $17.73 | $16.80 | +1,231% |
| February, 2028 | $22.71 | $17.54 | $22.34 | +1,608% |
| March, 2028 | $23.77 | $22.51 | $22.80 | +1,687% |
| April, 2028 | $19.76 | $19.54 | $20.36 | +1,386% |
| May, 2028 | $24.83 | $19.23 | $24.46 | +1,767% |
| June, 2028 | $24.97 | $24.57 | $24.31 | +1,777% |
| July, 2028 | $21.03 | $21.36 | $24.73 | +1,481% |
| August, 2028 | $27.53 | $20.93 | $25.47 | +1,970% |
| September, 2028 | $28.34 | $26.61 | $26.58 | +2,031% |
| October, 2028 | $22.48 | $25.22 | $26.65 | +1,590% |
| November, 2028 | $30.49 | $22.63 | $22.06 | +2,192% |
| December, 2028 | $28.30 | $28.65 | $28.70 | +2,028% |
Telomir Pharmaceuticals Inc Stock (TELO) Price Forecast for 2029
The 2029 price forecast for Telomir Pharmaceuticals Inc Stock (TELO) is $29.69 on average, with a high prediction of $35.05 and a low estimate of $24.33. This represents an +2,133% increase from the previous price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $24.33 | $27.07 | $28.58 | +1,729% |
| February, 2029 | $24.04 | $24.33 | $23.76 | +1,708% |
| March, 2029 | $30.48 | $30.83 | $30.82 | +2,192% |
| April, 2029 | $31.48 | $30.70 | $30.51 | +2,267% |
| May, 2029 | $26.39 | $26.80 | $27.92 | +1,884% |
| June, 2029 | $33.30 | $26.03 | $32.93 | +2,404% |
| July, 2029 | $32.83 | $32.74 | $32.41 | +2,369% |
| August, 2029 | $28.64 | $28.61 | $32.44 | +2,053% |
| September, 2029 | $36.15 | $27.73 | $34.09 | +2,618% |
| October, 2029 | $34.80 | $34.78 | $35.05 | +2,516% |
| November, 2029 | $30.10 | $30.42 | $34.37 | +2,163% |
| December, 2029 | $39.27 | $29.43 | $28.97 | +2,853% |
Telomir Pharmaceuticals Inc Stock (TELO) Price Forecast for 2030
Telomir Pharmaceuticals Inc Stock (TELO) is expected to reach an average price of $37.33 in 2030, with a high forecast of $43.53 and a low forecast of $31.13. This signifies an +2,707% surge from the last price of $1.33.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $38.36 | $36.82 | $37.17 | +2,784% |
| February, 2030 | $31.74 | $34.48 | $36.29 | +2,286% |
| March, 2030 | $30.93 | $31.13 | $30.74 | +2,226% |
| April, 2030 | $38.80 | $39.15 | $39.29 | +2,817% |
| May, 2030 | $36.36 | $38.41 | $38.22 | +2,634% |
| June, 2030 | $33.33 | $33.78 | $33.30 | +2,406% |
| July, 2030 | $40.88 | $32.83 | $41.41 | +2,974% |
| August, 2030 | $41.12 | $40.91 | $40.15 | +2,992% |
| September, 2030 | $35.74 | $35.86 | $37.36 | +2,587% |
| October, 2030 | $43.90 | $34.53 | $43.53 | +3,201% |
| November, 2030 | $42.66 | $42.95 | $42.81 | +3,108% |
| December, 2030 | $37.35 | $37.68 | $42.08 | +2,708% |
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):